Paul Parren, PhD

Founder and CSO at Gyes BV

Speaker

Prof. Paul W.H.I. Parren is dedicated to translating antibody knowledge into innovative therapeutics and technologies. He holds a PhD in molecular immunology from the University of Amsterdam (1992). Prof. Parren was an Associate Professor at The Scripps Research Institute in La Jolla, California. From 2002-2017, he led research and preclinical development at Genmab, leading to eight antibody product approvals to date. He is a tenured Professor of Molecular Immunology at the Leiden University Medical Center in Leiden. He is Executive Vice President at LAVA Therapeutics NV, a publicly traded biotechnology company that develops bispecific gamma-delta T cell engagers to transform cancer therapy.